Literature DB >> 1977086

Formation of amyloid-like fibrils in COS cells overexpressing part of the Alzheimer amyloid protein precursor.

K Maruyama1, K Terakado, M Usami, K Yoshikawa.   

Abstract

A pathological hallmark of Alzheimer's disease is the deposition of amyloid fibrils in the brain. The principal component of the amyloid fibril is beta/A4 protein, which is derived from a large membrane-bound glycoprotein, Alzheimer amyloid protein precursor (APP). Although the deposition of amyloid is thought to result from the aberrant processing of APP, the detailed molecular mechanisms of amyloidogenesis remain unclear. A C-terminal fragment of APP which spans the beta/A4 and cytoplasmic domains has a tendency to self-aggregate. In an attempt to establish a cultured-cell model for amyloid fibril formation, we have transfected COS-1 cells with complementary DNA encoding the C-terminal 100 residues of APP. In the perinuclear regions of a small population of DNA-transfected cells, we observed inclusion-like deposits which showed a strong immunohistochemical reaction towards an anti-C-terminal APP antibody or an anti-beta/A4 amyloid core-specific antibody. Electron microscope observations of the inclusion-carrying cells revealed an accumulation of amyloid-like fibrils of 8-22 nm diameter near and on the nuclear membrane. The fibrils showed a beaded or helical structure, and reacted positively with the anti-C-terminus antibody by immunoelectron microscopy. These results suggest that the formation of amyloid fibrils is an inherent characteristic of the C-terminal peptide of APP. The present system provides a suitable model for the molecular dissection of the process of brain amyloidogenesis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1977086     DOI: 10.1038/347566a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  21 in total

1.  Adenosine 3',5'-cyclic monophosphate increases processing of amyloid precursor protein (APP) to beta-amyloid in neuroblastoma cells without changing APP levels or expression of APP mRNA.

Authors:  A Kumar; F G La Rosa; A R Hovland; W C Cole; J Edwards-Prasad; K N Prasad
Journal:  Neurochem Res       Date:  1999-10       Impact factor: 3.996

2.  Alzheimer's beta-secretase, beta-site amyloid precursor protein-cleaving enzyme, is responsible for cleavage secretion of a Golgi-resident sialyltransferase.

Authors:  S Kitazume; Y Tachida; R Oka; K Shirotani; T C Saido; Y Hashimoto
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-06       Impact factor: 11.205

3.  Neuronal cell death in Alzheimer's disease correlates with apoE uptake and intracellular Abeta stabilization.

Authors:  F M LaFerla; J C Troncoso; D K Strickland; C H Kawas; G Jay
Journal:  J Clin Invest       Date:  1997-07-15       Impact factor: 14.808

Review 4.  The role of beta-amyloid in the development of Alzheimer's disease.

Authors:  K Ii
Journal:  Drugs Aging       Date:  1995-08       Impact factor: 3.923

5.  High-level expression and in vitro mutagenesis of a fibrillogenic 109-amino-acid C-terminal fragment of Alzheimer's-disease amyloid precursor protein.

Authors:  J E Gardella; G A Gorgone; L Candela; J Ghiso; E M Castaño; B Frangione; P D Gorevic
Journal:  Biochem J       Date:  1993-09-15       Impact factor: 3.857

6.  Abnormal distribution of cathepsin proteinases and endogenous inhibitors (cystatins) in the hippocampus of patients with Alzheimer's disease, parkinsonism-dementia complex on Guam, and senile dementia and in the aged.

Authors:  K Ii; H Ito; E Kominami; A Hirano
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

7.  Activation of neuronal caspase-3 by intracellular accumulation of wild-type Alzheimer amyloid precursor protein.

Authors:  T Uetsuki; K Takemoto; I Nishimura; M Okamoto; M Niinobe; T Momoi; M Miura; K Yoshikawa
Journal:  J Neurosci       Date:  1999-08-15       Impact factor: 6.167

8.  The presenilin 2 mutation (N141I) linked to familial Alzheimer disease (Volga German families) increases the secretion of amyloid beta protein ending at the 42nd (or 43rd) residue.

Authors:  T Tomita; K Maruyama; T C Saido; H Kume; K Shinozaki; S Tokuhiro; A Capell; J Walter; J Grünberg; C Haass; T Iwatsubo; K Obata
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-04       Impact factor: 11.205

9.  Relative sensitivity of undifferentiated and cyclic adenosine 3',5'-monophosphate-induced differentiated neuroblastoma cells to cyclosporin A: potential role of beta-amyloid and ubiquitin in neurotoxicity.

Authors:  A Kumar; A R Hovland; F G La Rosa; W C Cole; J E Prasad; K N Prasad
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000-02       Impact factor: 2.416

10.  Brain transplants of cells expressing the carboxyl-terminal fragment of the Alzheimer amyloid protein precursor cause specific neuropathology in vivo.

Authors:  R L Neve; A Kammesheidt; C F Hohmann
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.